Go Deep
HeartSciences Inc.
HeartSciences Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -39,606 | -1.0 | -7.58 | 17.41 | 301.19 |
| Oct 2026 | -39,263 | -0.9 | -7.20 | 17.41 | 286.04 |
| Oct 2026 | -41,170 | -1.0 | -7.31 | 17.41 | 291.09 |
| Oct 2026 | -41,299 | -1.0 | -7.46 | 17.41 | 296.78 |
| Oct 2026 | -42,155 | -1.1 | -8.48 | 17.41 | 336.71 |
| Oct 2026 | -41,319 | -1.0 | -7.55 | 17.41 | 299.22 |
HeartSciences Inc. Quarterly Results
| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 |
|---|---|---|---|---|
| Revenue | 2,100.0 | 0.0 | 0.0 | 2,419.0 |
| Net Profit | -3,172,344.0 | -2,750,904.0 | -1,985,208.0 | -2,350,769.0 |
| EPS | -0.9 | — | -0.6 | -0.8 |
HeartSciences Inc. Revenue & Profit: Last 5 Years
| Line Item | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 |
|---|---|---|---|---|---|
| Revenue | 4,319.0 | 4,350.0 | 18,600.0 | 5,150.0 | — |
| Net Profit | -9,141,875.0 | -8,765,229.0 | -6,605,208.0 | -6,354,290.0 | — |
| EPS | -3.5 | -9.3 | -18.7 | -80.0 | — |
HeartSciences Inc. Balance Sheet
| Line Item | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 |
|---|---|---|---|---|---|
| Total Assets | 5,262,673.0 | 4,222,909.0 | 9,503,113.0 | 3,287,233.0 | — |
| Total Liabilities | 5,036,613.0 | 4,017,738.0 | 2,185,812.0 | 3,056,676.0 | — |
| Total Equity | 226,060.0 | 205,171.0 | 7,317,301.0 | 230,557.0 | — |
Owes vs Owns
HeartSciences Inc. owed $1.54 for every $1 it owned in Jul 2026, up from $0.93 in Apr 2023.
| Period | Jul 2026 | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 |
|---|---|---|---|---|---|
| Owes vs Owns | 1.54× | 0.96× | 0.95× | 0.23× | 0.93× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
HeartSciences Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Apr 2026
Cash & short-term investments 31.5%Inventory 12.5%Fixed assets (tangible) 5.8%Intangible assets 45.1%Other assets 5.1%
How it's funded — Apr 2026
Short-term debt 68.8%Long-term debt 3.3%Payables 6.0%Other liabilities 17.5%Shareholders' equity 4.3%
| Line Item | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 1.7 | 1.1 | 5.8 | 1.7 |
| Receivables | 0.0 | 0.0 | 0.0 | 0.0 |
| Inventory | 0.7 | 0.7 | 0.6 | 0.7 |
| Fixed assets (tangible) | 0.3 | 0.4 | 0.6 | 0.6 |
| Intangible assets | 2.4 | 1.6 | 1.6 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 0.3 | 0.4 | 0.9 | 0.4 |
| Liabilities & equity | ||||
| Short-term debt | 3.6 | 2.6 | 0.5 | 0.5 |
| Long-term debt | 0.2 | 0.3 | 0.4 | 0.5 |
| Payables | 0.3 | 0.3 | 0.4 | 0.6 |
| Other liabilities | 0.9 | 0.8 | 0.8 | 1.4 |
| Shareholders' equity | 0.2 | 0.2 | 7.3 | 0.2 |
| Net tangible assets | -2.1 | -1.4 | 5.7 | 0.2 |
HeartSciences Inc. Cash Flow
| Line Item | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 |
|---|---|---|---|---|---|
| Operating Activities | -7,426,707.0 | -7,412,994.0 | -6,070,185.0 | -5,773,577.0 | — |
| Investing Activities | -44,452.0 | -30,188.0 | -125,271.0 | -18,308.0 | — |
| Financing Activities | 8,029,875.0 | 2,733,632.0 | 10,342,637.0 | 6,534,092.0 | — |